GGG

GENTIAN DIAGNOSTICS ASA

No trades
See on Supercharts

GENT fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Gentian Diagnostics ASA engages in the research, development, production, marketing, and distribution of immunoassays. Its products include GCAL Calprotrectin, Crystatin C, Retinol-Binding Protein, Canine CRP, SARS-CoV-2 Total Ab, NT-proBNP Pre-Launch, BÜHLMANN products, IFU documents, and safety data sheets. The company was founded by Erling M. H. Sundrehagen and Bård Sundrehagen in 2001 and is headquartered in Moss, Norway.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

GENT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company